losartan has been researched along with scopolamine hydrobromide in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barnes, JC; Dennes, RP | 1 |
| Bill, DJ; Dourish, CT; Grewal, SS; McLenachan, A; Shepherd, J; Stanhope, KJ | 1 |
| Chalas, A; Conway, EL | 1 |
| Chopra, K; Kulkarni, SK; Raghavendra, V | 2 |
| Endo, S; Fukumori, R; Hagiwara, Y; Kubo, T | 1 |
| Hagiwara, Y; Kubo, T | 2 |
| Hagiwara, Y; Kubo, T; Ohi, M | 1 |
| Gard, P; Jackson, A; Mechaeil, R; Rusted, J | 1 |
| Ababei, DC; Bild, V; Bild, W; Ciobică, A; Lefter, RM; Rusu, RN | 1 |
1 review(s) available for losartan and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for losartan and scopolamine hydrobromide
| Article | Year |
|---|---|
Cognitive enhancement following acute losartan in normotensive young adults.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cognition; Cognition Disorders; Double-Blind Method; Female; Humans; Losartan; Male; Memory, Episodic; Neuropsychological Tests; Nootropic Agents; Scopolamine; Young Adult | 2011 |
13 other study(ies) available for losartan and scopolamine hydrobromide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bridged Bicyclo Compounds; Cholinergic Agents; Dose-Response Relationship, Drug; Imidazoles; Injections, Intraventricular; Losartan; Male; Maze Learning; Memory; Memory, Short-Term; N-Methylscopolamine; Parasympatholytics; Physostigmine; Pilocarpine; Rats; Scopolamine; Scopolamine Derivatives; Space Perception; Spiro Compounds; Tetrazoles | 1993 |
Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Biphenyl Compounds; Diazepam; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Memory; Motor Activity; Pyridines; Rats; Rats, Sprague-Dawley; Scopolamine; Tetrazoles | 1996 |
No evidence for involvement of angiotensin II in spatial learning in water maze in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cholinergic Antagonists; Diazepam; GABA Modulators; Imidazoles; Injections, Intraventricular; Losartan; Maze Learning; Memory; Organophosphorus Compounds; Proline; Psychomotor Performance; Rats; Renin; Scopolamine; Tetrazoles | 1996 |
Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.
Topics: Angiotensin Receptor Antagonists; Animals; Avoidance Learning; Cholinergic Agents; Cholinesterase Inhibitors; Female; Losartan; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred BALB C; Motor Activity; Muscarinic Antagonists; Nootropic Agents; Physostigmine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Scopolamine; Space Perception | 1998 |
Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Avoidance Learning; Captopril; Dizocilpine Maleate; Electroshock; Enzyme Inhibitors; Losartan; Male; Memory; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Reaction Time; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Scopolamine | 2001 |
Activation of hypothalamic angiotensin receptors produces pressor responses via cholinergic inputs to the rostral ventrolateral medulla in normotensive and hypertensive rats.
Topics: Acetylcholine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Carbachol; Cholinergic Agonists; Cholinergic Fibers; Cholinesterase Inhibitors; Electric Stimulation; gamma-Aminobutyric Acid; Hypertension; Hypothalamus, Anterior; Iontophoresis; Losartan; Male; Medulla Oblongata; Microinjections; Muscarinic Antagonists; Neural Pathways; Physostigmine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Scopolamine; Vasoconstrictor Agents | 2002 |
Tonic angiotensinergic inputs to neurons in the anterior hypothalamic area of rats.
Topics: Acetylcholine; Action Potentials; Adrenergic alpha-Agonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Anterior Hypothalamic Nucleus; Anti-Arrhythmia Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Imidazoles; Losartan; Male; Muscarinic Antagonists; Neurons; Phenylephrine; Pyridines; Rats; Rats, Wistar; Scopolamine | 2004 |
Cholinergic stimulation in the lateral septal area activates anterior hypothalamic area neurons via excitatory amino acid receptors in rats.
Topics: Acetylcholine; Action Potentials; Angiotensin II Type 1 Receptor Blockers; Animals; Anterior Hypothalamic Nucleus; Carbachol; Cholinergic Agonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Kynurenic Acid; Losartan; Male; Microinjections; Muscarinic Antagonists; Neural Pathways; Neurons; Rats; Rats, Wistar; Receptors, Glutamate; Scopolamine; Septum of Brain | 2005 |
Cholinergic stimulation in the posterior hypothalamic nucleus activates angiotensin II-sensitive neurons in the anterior hypothalamic area of rats.
Topics: Acetylcholine; Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anterior Hypothalamic Nucleus; Carbachol; Cholinergic Agonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hypothalamus, Posterior; Losartan; Male; Microinjections; Muscarinic Antagonists; Neurons; Physostigmine; Rats; Rats, Wistar; Scopolamine; Time Factors | 2005 |
A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Losartan; Male; Maze Learning; Memory Disorders; Memory, Long-Term; Memory, Short-Term; Mice; Muscarinic Antagonists; Ramipril; Renin-Angiotensin System; Scopolamine; Spatial Memory | 2019 |